INSPIRNA
Inspirna (formerly Rgenix) is a clinical-stage biopharmaceutical company developing first-in-class/best-in-class drug candidates that target critical cancer drivers. Our discovery platform leverages RNA biology to discover novel RNA dysregulated cancer drivers that can be targeted by small molecules and biologics. Clinical programs are first-in-class oral small molecules in development for patients with RAS mutant CRC (RGX-202; Phase 1b) as well as SCLC and NSCLC (RGX-104; Phase 1b/2)
INSPIRNA
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.inspirna.com
Total Employee:
11+
Status:
Active
Contact:
(646) 856-9261
Email Addresses:
[email protected]
Total Funding:
144.6 M USD
Technology used in webpage:
SPF Euro Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator Dropbox Business
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
MindMed
MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
The New York City Investment Fund
The New York City Investment Fund investment in Series D - Inspirna
Sixty Degree Capital
Sixty Degree Capital investment in Series D - Inspirna
Sofinnova Partners
Sofinnova Partners investment in Series D - Inspirna
Dreavent 6
Dreavent 6 investment in Series D - Inspirna
Novo Holdings
Novo Holdings investment in Series D - Inspirna
Sands Capital Ventures
Sands Capital Ventures investment in Series D - Inspirna
Vivo Capital
Vivo Capital investment in Series D - Inspirna
Lepu Medical
Lepu Medical investment in Series D - Inspirna
Lepu Medical
Lepu Medical investment in Series C - Inspirna
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Inspirna
Official Site Inspections
http://www.inspirna.com Semrush global rank: 3.61 M Semrush visits lastest month: 3.96 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
